200 related articles for article (PubMed ID: 32024502)
1. Betulinic acid shows anticancer activity against equine melanoma cells and permeates isolated equine skin in vitro.
Weber LA; Meißner J; Delarocque J; Kalbitz J; Feige K; Kietzmann M; Michaelis A; Paschke R; Michael J; Pratscher B; Cavalleri JV
BMC Vet Res; 2020 Feb; 16(1):44. PubMed ID: 32024502
[TBL] [Abstract][Full Text] [Related]
2. In vitro assessment of triterpenoids NVX-207 and betulinyl-bis-sulfamate as a topical treatment for equine skin cancer.
Weber LA; Funtan A; Paschke R; Delarocque J; Kalbitz J; Meißner J; Feige K; Kietzmann M; Cavalleri JV
PLoS One; 2020; 15(11):e0241448. PubMed ID: 33151949
[TBL] [Abstract][Full Text] [Related]
3. In vitro anticancer activity of Betulinic acid and derivatives thereof on equine melanoma cell lines from grey horses and in vivo safety assessment of the compound NVX-207 in two horses.
Liebscher G; Vanchangiri K; Mueller T; Feige K; Cavalleri JM; Paschke R
Chem Biol Interact; 2016 Feb; 246():20-9. PubMed ID: 26772157
[TBL] [Abstract][Full Text] [Related]
4. Concentration profiles and safety of topically applied betulinic acid and NVX-207 in eight healthy horses-A randomized, blinded, placebo-controlled, crossover pilot study.
Weber LA; Puff C; Kalbitz J; Kietzmann M; Feige K; Bosse K; Rohn K; Cavalleri JV
J Vet Pharmacol Ther; 2021 Jan; 44(1):47-57. PubMed ID: 32845519
[TBL] [Abstract][Full Text] [Related]
5. Transient activation of EGFR/AKT cell survival pathway and expression of survivin contribute to reduced sensitivity of human melanoma cells to betulinic acid.
Qiu L; Wang Q; Di W; Jiang Q; Schefeller E; Derby S; Wanebo H; Yan B; Wan Y
Int J Oncol; 2005 Sep; 27(3):823-30. PubMed ID: 16077934
[TBL] [Abstract][Full Text] [Related]
6. Preparation of amino acid conjugates of betulinic acid with activity against human melanoma.
Jeong HJ; Chai HB; Park SY; Kim DS
Bioorg Med Chem Lett; 1999 Apr; 9(8):1201-4. PubMed ID: 10328313
[TBL] [Abstract][Full Text] [Related]
7. Betulinic acid augments the inhibitory effects of vincristine on growth and lung metastasis of B16F10 melanoma cells in mice.
Sawada N; Kataoka K; Kondo K; Arimochi H; Fujino H; Takahashi Y; Miyoshi T; Kuwahara T; Monden Y; Ohnishi Y
Br J Cancer; 2004 Apr; 90(8):1672-8. PubMed ID: 15083202
[TBL] [Abstract][Full Text] [Related]
8. Additive Interactions between Betulinic Acid and Two Taxanes in In Vitro Tests against Four Human Malignant Melanoma Cell Lines.
Wróblewska-Łuczka P; Cabaj J; Bąk W; Bargieł J; Grabarska A; Góralczyk A; Łuszczki JJ
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077036
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and studies of anticancer properties of lupane-type triterpenoid derivatives containing a cisplatin fragment.
Emmerich D; Vanchanagiri K; Baratto LC; Schmidt H; Paschke R
Eur J Med Chem; 2014 Mar; 75():460-6. PubMed ID: 24561674
[TBL] [Abstract][Full Text] [Related]
10. Approaches to improve the oral bioavailability and effects of novel anticancer drugs berberine and betulinic acid.
Godugu C; Patel AR; Doddapaneni R; Somagoni J; Singh M
PLoS One; 2014; 9(3):e89919. PubMed ID: 24614362
[TBL] [Abstract][Full Text] [Related]
11. Characterization and in vitro studies of the anticancer effect of oxidized carbon nanotubes functionalized with betulinic acid.
Tan JM; Karthivashan G; Arulselvan P; Fakurazi S; Hussein MZ
Drug Des Devel Ther; 2014; 8():2333-43. PubMed ID: 25429205
[TBL] [Abstract][Full Text] [Related]
12. Betulinic acid induces apoptosis in skin cancer cells and differentiation in normal human keratinocytes.
Galgon T; Wohlrab W; Dräger B
Exp Dermatol; 2005 Oct; 14(10):736-43. PubMed ID: 16176281
[TBL] [Abstract][Full Text] [Related]
13. Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis.
Pisha E; Chai H; Lee IS; Chagwedera TE; Farnsworth NR; Cordell GA; Beecher CW; Fong HH; Kinghorn AD; Brown DM
Nat Med; 1995 Oct; 1(10):1046-51. PubMed ID: 7489361
[TBL] [Abstract][Full Text] [Related]
14. A Review of Electroporation-based Antitumor Skin Therapies and Investigation of Betulinic Acid-loaded Ointment.
Bakonyi M; Berko S; Eros G; Varju G; Dehelean CA; Budai-Szucs M; Csanyi E
Anticancer Agents Med Chem; 2018; 18(5):693-701. PubMed ID: 29141562
[TBL] [Abstract][Full Text] [Related]
15. Enhancing the divergent activities of betulinic acid via neoglycosylation.
Goff RD; Thorson JS
Org Lett; 2009 Jan; 11(2):461-4. PubMed ID: 19102682
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological evaluation of C-3 modified Betulinic acid derivatives with potent anticancer activity.
Rajendran P; Jaggi M; Singh MK; Mukherjee R; Burman AC
Invest New Drugs; 2008 Feb; 26(1):25-34. PubMed ID: 17851638
[TBL] [Abstract][Full Text] [Related]
17. Apoptotic activity of betulinic acid derivatives on murine melanoma B16 cell line.
Liu WK; Ho JC; Cheung FW; Liu BP; Ye WC; Che CT
Eur J Pharmacol; 2004 Sep; 498(1-3):71-8. PubMed ID: 15363977
[TBL] [Abstract][Full Text] [Related]
18. Equine melanocytic tumors: a retrospective study of 53 horses (1988 to 1991).
Valentine BA
J Vet Intern Med; 1995; 9(5):291-7. PubMed ID: 8531173
[TBL] [Abstract][Full Text] [Related]
19. A potent tumoricidal co-drug 'Bet-CA'--an ester derivative of betulinic acid and dichloroacetate selectively and synergistically kills cancer cells.
Saha S; Ghosh M; Dutta SK
Sci Rep; 2015 Jan; 5():7762. PubMed ID: 25585916
[TBL] [Abstract][Full Text] [Related]
20. Enhanced cytotoxicity of bleomycin, cisplatin, and carboplatin on equine sarcoid cells following electroporation-mediated delivery in vitro.
Souza C; Villarino NF; Farnsworth K; Black ME
J Vet Pharmacol Ther; 2017 Jan; 40(1):97-100. PubMed ID: 27287308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
